vs

Side-by-side financial comparison of i-80 Gold Corp. (IAUX) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

RECURSION PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($35.5M vs $21.3M, roughly 1.7× i-80 Gold Corp.). RECURSION PHARMACEUTICALS, INC. runs the higher net margin — -304.2% vs -401.9%, a 97.6% gap on every dollar of revenue. i-80 Gold Corp. produced more free cash flow last quarter ($-39.2M vs $-47.3M).

i-80 Gold Corp is a mineral exploration and development firm focused on gold and silver asset operations in Nevada, US. It advances high-potential mining projects, using responsible extraction practices to deliver precious metals to global industrial and investment markets.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

IAUX vs RXRX — Head-to-Head

Bigger by revenue
RXRX
RXRX
1.7× larger
RXRX
$35.5M
$21.3M
IAUX
Higher net margin
RXRX
RXRX
97.6% more per $
RXRX
-304.2%
-401.9%
IAUX
More free cash flow
IAUX
IAUX
$8.1M more FCF
IAUX
$-39.2M
$-47.3M
RXRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IAUX
IAUX
RXRX
RXRX
Revenue
$21.3M
$35.5M
Net Profit
$-85.6M
$-108.1M
Gross Margin
22.0%
59.8%
Operating Margin
-291.6%
-304.8%
Net Margin
-401.9%
-304.2%
Revenue YoY
681.7%
Net Profit YoY
39.6%
EPS (diluted)
$-0.10
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IAUX
IAUX
RXRX
RXRX
Q4 25
$21.3M
$35.5M
Q3 25
$32.0M
$5.2M
Q2 25
$27.8M
$19.2M
Q1 25
$14.0M
$14.7M
Q4 24
$4.5M
Q3 24
$11.5M
$26.1M
Q2 24
$7.2M
$14.4M
Q1 24
$13.8M
Net Profit
IAUX
IAUX
RXRX
RXRX
Q4 25
$-85.6M
$-108.1M
Q3 25
$-41.9M
$-162.3M
Q2 25
$-30.2M
$-171.9M
Q1 25
$-41.2M
$-202.5M
Q4 24
$-178.9M
Q3 24
$-43.1M
$-95.8M
Q2 24
$-41.0M
$-97.5M
Q1 24
$-91.4M
Gross Margin
IAUX
IAUX
RXRX
RXRX
Q4 25
22.0%
59.8%
Q3 25
9.7%
-183.8%
Q2 25
2.9%
-4.9%
Q1 25
20.7%
-48.0%
Q4 24
-181.4%
Q3 24
-42.7%
53.7%
Q2 24
-171.4%
36.2%
Q1 24
19.1%
Operating Margin
IAUX
IAUX
RXRX
RXRX
Q4 25
-291.6%
-304.8%
Q3 25
-86.7%
-3327.6%
Q2 25
-67.4%
-916.8%
Q1 25
-112.3%
-1297.9%
Q4 24
-4042.4%
Q3 24
-210.0%
-377.1%
Q2 24
-435.2%
-697.4%
Q1 24
-698.4%
Net Margin
IAUX
IAUX
RXRX
RXRX
Q4 25
-401.9%
-304.2%
Q3 25
-130.8%
-3135.3%
Q2 25
-108.5%
-894.2%
Q1 25
-293.3%
-1373.3%
Q4 24
-3935.5%
Q3 24
-374.5%
-367.5%
Q2 24
-570.8%
-676.6%
Q1 24
-662.4%
EPS (diluted)
IAUX
IAUX
RXRX
RXRX
Q4 25
$-0.10
$-0.17
Q3 25
$-0.05
$-0.36
Q2 25
$-0.05
$-0.41
Q1 25
$-0.10
$-0.50
Q4 24
$-0.56
Q3 24
$-0.11
$-0.34
Q2 24
$-0.11
$-0.40
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IAUX
IAUX
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$63.2M
$743.3M
Total DebtLower is stronger
$174.7M
$9.6M
Stockholders' EquityBook value
$346.8M
$1.1B
Total Assets
$703.4M
$1.5B
Debt / EquityLower = less leverage
0.50×
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IAUX
IAUX
RXRX
RXRX
Q4 25
$63.2M
$743.3M
Q3 25
$102.9M
$659.8M
Q2 25
$133.7M
$525.1M
Q1 25
$13.5M
$500.5M
Q4 24
$594.4M
Q3 24
$21.8M
$427.6M
Q2 24
$47.8M
$474.3M
Q1 24
$296.3M
Total Debt
IAUX
IAUX
RXRX
RXRX
Q4 25
$174.7M
$9.6M
Q3 25
$175.9M
$11.9M
Q2 25
$175.8M
$14.2M
Q1 25
$197.5M
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
IAUX
IAUX
RXRX
RXRX
Q4 25
$346.8M
$1.1B
Q3 25
$423.0M
$1.0B
Q2 25
$463.5M
$919.1M
Q1 25
$318.0M
$933.9M
Q4 24
$1.0B
Q3 24
$346.9M
$524.6M
Q2 24
$377.2M
$584.4M
Q1 24
$401.2M
Total Assets
IAUX
IAUX
RXRX
RXRX
Q4 25
$703.4M
$1.5B
Q3 25
$756.2M
$1.4B
Q2 25
$782.9M
$1.3B
Q1 25
$659.0M
$1.3B
Q4 24
$1.4B
Q3 24
$726.5M
Q2 24
$775.9M
Q1 24
$557.8M
Debt / Equity
IAUX
IAUX
RXRX
RXRX
Q4 25
0.50×
0.01×
Q3 25
0.42×
0.01×
Q2 25
0.38×
0.02×
Q1 25
0.62×
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IAUX
IAUX
RXRX
RXRX
Operating Cash FlowLast quarter
$-34.3M
$-46.1M
Free Cash FlowOCF − Capex
$-39.2M
$-47.3M
FCF MarginFCF / Revenue
-184.3%
-133.1%
Capex IntensityCapex / Revenue
23.1%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.2M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IAUX
IAUX
RXRX
RXRX
Q4 25
$-34.3M
$-46.1M
Q3 25
$-15.2M
$-117.4M
Q2 25
$-11.3M
$-76.4M
Q1 25
$-22.7M
$-132.0M
Q4 24
$-115.4M
Q3 24
$-23.5M
$-59.2M
Q2 24
$-24.6M
$-82.2M
Q1 24
$-102.3M
Free Cash Flow
IAUX
IAUX
RXRX
RXRX
Q4 25
$-39.2M
$-47.3M
Q3 25
$-18.5M
$-117.6M
Q2 25
$-12.4M
$-79.6M
Q1 25
$-23.1M
$-133.8M
Q4 24
$-116.7M
Q3 24
$-23.8M
$-63.8M
Q2 24
$-25.1M
$-83.4M
Q1 24
$-109.0M
FCF Margin
IAUX
IAUX
RXRX
RXRX
Q4 25
-184.3%
-133.1%
Q3 25
-57.8%
-2272.5%
Q2 25
-44.7%
-413.9%
Q1 25
-164.1%
-907.4%
Q4 24
-2567.7%
Q3 24
-206.7%
-244.6%
Q2 24
-349.1%
-578.5%
Q1 24
-789.9%
Capex Intensity
IAUX
IAUX
RXRX
RXRX
Q4 25
23.1%
3.5%
Q3 25
10.2%
4.7%
Q2 25
3.9%
16.4%
Q1 25
2.5%
12.4%
Q4 24
28.6%
Q3 24
2.5%
17.5%
Q2 24
7.3%
8.2%
Q1 24
48.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IAUX
IAUX

Granite Creek Mining Company$20.3M95%
Ruby Hill Mining Company LLC$991.0K5%
Lone Tree Minning Company$3.0K0%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons